1-1 of 1
Matthew Streetly, BM, BS
Close
Sort by
Journal Articles

Alternate Day Actimid™ (CC-4047) Is Well Tolerated and Is Active When Used to Treat Relapsed/Refractory Myeloma.

Matthew Streetly, BM, BS, Kylie Gyertson, Majid Kazmi, Jerome Zeldis, Steve A. Schey
Journal: Blood
Blood (2004) 104 (11): 332.
https://doi.org/10.1182/blood.V104.11.332.332
Published: 2004